title: UCSF Protocol for Caries Arrest Using Silver Diamine Fluoride: Rationale, Indications and Consent.
abstract: The Food and Drug Administration recently cleared silver diamine fluoride for reducing tooth sensitivity. Clinical trials document arrest and prevention of dental caries by silver diamine fluoride. This off-label use is now permissible and appropriate under U.S. law. A CDT code was approved for caries arresting medicaments for 2016 to facilitate documentation and billing. We present a systematic review, clinical indications, clinical protocol and consent procedure to guide application for caries arrest treatment.
authors.forename: Jeremy A
authors.initials: JA
authors.lastname: Horst
authors.forename: Hellene
authors.initials: H
authors.lastname: Ellenikiotis
authors.forename: Peter L
authors.initials: PL
authors.lastname: Milgrom
mesh_terms: D002327:Cariostatic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002985:Clinical Protocols; D003731:Dental Caries / Q000517:prevention & control*; D057133:Dentin Desensitizing Agents / Q000627:therapeutic use; D005460:Fluorides, Topical; D006801:Humans; D056687:Off-Label Use / Q000331:legislation & jurisprudence; D000644:Quaternary Ammonium Compounds / Q000008:administration & dosage / Q000627:therapeutic use*; D012495:San Francisco; D018030:Silver Compounds; D000078202:Systematic Reviews as Topic; D014089:Tooth Remineralization / Q000379:methods; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D002327:Cariostatic Agents; D057133:Dentin Desensitizing Agents; D005460:Fluorides, Topical; D000644:Quaternary Ammonium Compounds; D018030:Silver Compounds; C024633:silver diamine fluoride